Skip to main content
Health and Quality of Life Outcomes logoLink to Health and Quality of Life Outcomes
. 2026 May 21;24:95. doi: 10.1186/s12955-026-02548-2

An exploratory analysis of interaction effects in EQ-5D valuation using saturated EQ VAS datasets from the Netherlands, the United Kingdom, and China

Zhihao Yang 1,2,✉, Juan M Ramos-Goñi 3,4, Paul Kind 5, Jan Busschbach 2
PMCID: PMC13374271  PMID: 42169114

Abstract

Objectives

To examine whether interaction terms improve predictive accuracy in EQ-5D valuation models using fully saturated datasets, and to identify parsimonious interaction specifications that balance model performance and feasibility.

Methods

A secondary analysis of three saturated EQ-5D visual analogue scale (VAS) datasets was conducted: EQ-5D-3 L from the Netherlands and the United Kingdom, and EQ-5D-5 L from China. The analysis followed three steps. First, main-effects models were estimated as a reference and compared with models including all second-order interaction terms. Second, the contribution of interaction terms was assessed by examining how model performance metrics (RMSE, R², AIC, and BIC) changed with the number of interaction terms included, and by ranking individual interaction terms according to their impact on RMSE across datasets. Third, parsimonious models using summary interaction terms were evaluated to capture key non-additive effects.

Results

Including interaction terms consistently improved predictive performance across all three datasets, although absolute improvements were modest. Interaction effects were strongest for combinations of severe health problems, and all interaction coefficients were positive, consistent with diminishing marginal utility. Interactions involving pain/discomfort and anxiety/depression were among the most influential across datasets. Parsimonious specifications incorporating summary interaction terms—N3D1 for EQ-5D-3 L and N45D1 for EQ-5D-5 L—captured much of the performance gain achieved by fully interacted models.

Conclusions

Interaction effects are empirically detectable and systematically improve model performance in EQ-5D valuation when saturated data are available. Summary interaction terms provide a practical approach to capturing key non-additive effects while maintaining model parsimony.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12955-026-02548-2.

Keywords: EQ-5D, Valuation, Interaction effects, Visual analogue scale

Highlights

Evidence on interaction effects in EQ-5D valuation has been limited by non-saturated study designs.

Using three fully saturated EQ-VAS datasets, interaction terms improved model performance, particularly for severe health states.

Parsimonious summary interaction terms capture key non-additive effects while maintaining feasibility for health state valuation and HEOR practice.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12955-026-02548-2.

Introduction

The EuroQol Valuation Technology (EQ-VT) design has provided a standardized framework for EQ-5D-5 L valuation studies since its inception, enabling comparability across countries and facilitating widespread adoption of EQ-5D-5 L in health economic evaluations [1–3]. The EQ-VT design—based on a relatively small number of health states with approximately 100 observations per state—represented a major improvement over earlier approaches and was considered sufficient for estimating main-effects (ME) models [4–6].

However, the reliance on ME models assumes that disutilities associated with problems in each EQ-5D dimension are independent and additive. This assumption has been increasingly questioned. Individuals experiencing multiple severe problems may perceive their combined impact differently than the sum of individual impairments [7–9]. The absence of strong evidence for interaction terms in early valuation studies may have reflected design limitations rather than a true lack of interactions: efficient designs optimized for ME estimation provided limited coverage of severe and implausible states, constraining the detectability of interactions [10, 11]. For example, concerns were raised in the review of the first English EQ-5D-5 L value set about whether the design sufficiently captured severe health states to test for interactions [12].

More recently, empirical studies have begun to identify interactions in EQ-5D valuation models [13, 14]. The Singapore EQ-5D-5 L value set explicitly included two interaction terms, demonstrating that models incorporating interactions can improve predictive performance relative to ME-only specifications [13]. In addition, Jonker et al. [8] applied an optimal scaling approach to Dutch EQ-5D data and similarly reported significant interaction effects, highlighting their importance for capturing preference heterogeneity. These findings add to earlier simulation evidence suggesting that ME models may be mis-specified if interactions are ignored [7, 12]. In EQ-5D-3 L valuation studies, interaction effects have been incorporated through summary terms such as N3 and D1. The N3 term, introduced in the UK MVH study [15], captures the additional disutility associated with the presence of any severe problem, while D1-type specifications, used in studies such as the US valuation [16], account for the cumulative burden of problems across dimensions. In EQ-5D-5 L valuation studies, similar attempts have been made to account for interaction effects, although no single standard specification has been established. In the recent Singapore EQ-5D-5 L valuation study, the inclusion of two two-way interaction terms improved model performance [13]. These approaches reflect attempts to capture the compounding impact of multiple impairments and suggest that interaction effects may play an important role in modelling preferences, particularly for more severe health states.

However, most published valuation studies lack the empirical coverage required to investigate interactions comprehensively. For instance, only 43 of 243 health states (17.7%) were directly valued in the EQ-5D-3 L [15], and 86 of 3,125 states (2.75%) in the EQ-5D-5 L [1]. This limited coverage makes it difficult to assess whether interactions systematically influence valuations, particularly for combinations of severe problems.

The emergence of saturated datasets valued using the visual analogue scale (VAS) provides a unique opportunity to address this gap. A saturated dataset refers to a dataset in which all possible health states defined by the EQ-5D descriptive system are directly valued at least once, ensuring full coverage of the health state space. In these datasets, all EQ-5D health states are directly valued, eliminating the sampling restrictions of conventional valuation studies and enabling a comprehensive assessment of interaction effects across the entire descriptive system.

Such full coverage is not feasible in conventional TTO or DCE valuation studies due to practical constraints on study design and respondent burden. As a result, VAS-based saturated datasets provide a unique platform for systematically examining interaction effects. Importantly, previous methodological studies have used such datasets to identify efficient health state sampling strategies, which were subsequently shown to perform well in TTO-based valuation studies [6, 11]. This suggests that, while VAS and TTO differ in their elicitation mechanisms, VAS data can provide a useful platform for testing methodological questions. Nevertheless, findings derived from VAS data should be interpreted with caution when considering their generalisability to TTO-based valuation.

Understanding whether and how interaction effects influence valuation models has important practical implications. If such effects are present and meaningful, they may inform model specification, improve predictive performance, and guide the design of valuation studies. In particular, identifying when interaction effects become relevant may help optimize health state selection and improve the efficiency of valuation designs. Against this background, the present study aimed to: (i) investigate whether including interaction terms improves predictive accuracy in EQ-5D valuation models using saturated EQ VAS datasets from the Netherlands, UK, and China; and (ii) identify parsimonious specifications that capture key interactions while remaining feasible for future valuation studies.

Methods

Data sources

This study utilized three saturated datasets: one EQ-5D-5 L VAS dataset collected in China [6] and two EQ-5D-3 L VAS datasets collected in the Netherlands [5] and the United Kingdom. In these datasets, all possible health states defined by the respective EQ-5D descriptive systems were directly valued, providing full coverage of the health state space. The Dutch EQ-5D-3 L dataset was derived from a saturation study in which 126 university students valued all 243 EQ-5D-3 L health states using EQ VAS. Health states were presented in 10 random orders to reduce framing effects, the procedure was piloted in advance, and the average completion time was 1 h 16 min [5].

The China EQ-5D-5 L dataset was derived from a direct EQ VAS valuation study in which 1603 university students valued all 3125 EQ-5D-5 L health states. To achieve approximately 100 observations per health state, the health states were divided into 16 blocks, and respondents valued one block each in organized group interview sessions [6].

The UK EQ-5D-3 L dataset was derived from a postal saturation study conducted in England and Wales in 2003. Twenty-one questionnaire variants were developed, each containing anchor states and a subset of EQ-5D-3 L health states, and 1,100 questionnaires were mailed to individuals sampled from electoral-register sources. The responding sample comprised 685 individuals, with approximately 25 to 38 respondents contributing to each questionnaire variant.

These three datasets were selected because they represent available saturated EQ-VAS datasets across both the EQ-5D-3 L and EQ-5D-5 L systems, allowing the investigation of interaction effects under full health-state coverage. However, the original studies were not designed to produce nationally representative samples for the present purpose. In particular, the Dutch and Chinese datasets were based on university student samples, whereas the UK dataset used a postal general-population sample that was older and better educated than the population benchmark. Accordingly, the present analysis should be interpreted as methodological rather than population-representative. The use of saturated datasets allowed a comprehensive examination of interaction effects across the full EQ-5D descriptive system, without the sampling limitations inherent in conventional valuation designs. Key characteristics of the datasets are summarized in Table 1.

Table 1.

Characteristics of the saturated EQ-5D valuation datasets

The Netherlands UK China
EQ-5D version 3 L 3 L 5 L
Mean number of observation per health state 123.84 44.63 101.02
Range of observation number per health state From 122 to 124 From 25 to 1364* From 98 to 1601#
Lowest value, state 8.88, 33333 7.64, 33333 14.50, 55555
Highest value, state 91.81, 11111 96.94, 11111 93.29, 11111
Sample population University students General public University students

* 1364 observations for 11111 and 33333 only, for other states, it is between 25 and 70

#1601 observations for 55555 only, for other states, it is between 98 and 101

Data analysis

Step 1: Baseline and fully interacted model estimation

As a reference point, we first estimated conventional main-effects (ME) models for each dataset. In these models, the mean VAS value for each health state was expressed as a function of dimension-specific dummy variables and a constant. For the EQ-5D-3 L datasets, ten dummy variables represented deviations from full health (level 1) to levels 2 and 3 across the five EQ-5D dimensions (Formula 1). For the EQ-5D-5 L dataset, twenty dummy variables represented deviations from level 1 to levels 2–5.

graphic file with name d33e429.gif 1

To examine the potential contribution of interaction effects, we then extended the ME models by including all possible second-order (two-way) interaction terms between dimension-level dummy variables. This resulted in 40 interaction terms for the EQ-5D-3 L datasets and 160 interaction terms for the EQ-5D-5 L dataset. These fully interacted models were estimated to assess whether interaction terms improved model performance relative to the ME specification and to explore the direction and magnitude of interaction effects across severity levels and dimensions.

Model performance for both ME and fully interacted models was evaluated using root mean squared error (RMSE), with additional goodness-of-fit statistics including R², Akaike information criterion (AIC), and Bayesian information criterion (BIC).

Step 2: Assessing the contribution of secondary interaction terms across datasets

To understand how interaction terms collectively influence model performance, we first examined how goodness-of-fit metrics changed as interaction terms were incrementally added to the model. Given the large number of possible interaction terms, it was not feasible to evaluate the effect of each term individually through sequential inclusion. Instead, we estimated a series of models in which interaction terms were added in increasing numbers, and plotted RMSE as a function of the number of interaction terms included. Interaction terms were added in arbitrary order to assess the general relationship between model complexity and performance, rather than to evaluate the marginal effect of any specific term. Corresponding analyses were conducted for R², AIC, and BIC. These analyses provide a general assessment of how increasing model complexity through additional interaction terms affects predictive performance and model fit.

These analyses provide a general assessment of how increasing model complexity through additional interaction terms affects predictive performance and model fit. RMSE results are presented in Figs. 1, 2 and 3, while corresponding figures for R², AIC, and BIC are reported in the supplementary material.

Fig. 1.

Fig. 1

RMSE over number of interaction terms, UK 3 L

Fig. 2.

Fig. 2

RMSE over number of interaction terms, Netherlands 3 L

Fig. 3.

Fig. 3

RMSE over number of interaction terms, China 5 L

While these plots illustrate the overall relationship between the number of interaction terms and model performance, they do not identify which specific interaction terms are most influential. Therefore, to further disentangle the contribution of individual secondary interaction terms, we conducted an auxiliary regression analysis in which RMSE was regressed on the inclusion of each interaction term. This approach allowed us to quantify the marginal contribution of individual interaction terms to RMSE reduction and to rank interaction terms according to their importance within each dataset. The results of this ranking exercise are presented in Table 4 and were used to identify interaction patterns that were consistent across the three datasets.

Table 4.

Effect of selected secondary interaction terms on RMSE values, with aligned comparison of the Netherlands and UK EQ-5D-3 L datasets

UK rank 3 L term UK coef Netherlands coef Netherlands rank 5 L term China coef
1 pd3ad3 -0.02359 -0.15480 1 pd4ad5 -0.00308
2 mo3pd3 -0.02009 -0.06912 2 pd5ad4 -0.00270
3 mo3ua3 -0.01773 -0.01895 25 sc5ua4 -0.00270
4 mo3ad3 -0.01473 -0.05901 4 mo4sc5 -0.00263
5 ua3pd3 -0.01375 -0.03490 10 mo5sc4 -0.00201
6 ua3ad3 -0.01143 -0.05046 6 mo4ua5 -0.00193
7 mo3sc3 -0.00835 -0.04800 7 sc4ua5 -0.00193
8 sc3pd3 -0.00657 -0.04195 8 mo3sc5 -0.00175
9 pd3ad2 -0.00500 -0.05297 5 mo2sc2 -0.00158
10 sc2ua3 -0.00467 -0.02300 21 sc5ua3 -0.00152
11 pd2ad3 -0.00256 -0.03099 13 pd3ad5 -0.00148
12 ua2pd3 -0.00255 -0.02712 17 pd3ad3 -0.00146
13 mo3sc2 -0.00254 -0.02039 24 mo5sc5 -0.00142
14 mo2sc3 -0.00250 -0.02334 20 pd5ad3 -0.00134
15 sc3ad3 -0.00249 -0.06308 3 sc5ua5 -0.00118
16 sc3ua2 -0.00243 -0.00576 37 mo3ua5 -0.00108
17 ua3ad2 -0.00235 -0.00885 35 sc2ua2 -0.00105
18 mo2pd3 -0.00233 -0.02685 18 mo4ad5 -0.00104
19 mo3ad2 -0.00223 -0.01397 29 mo5sc3 -0.00103
20 mo2sc2 -0.00213 0.000283 40 mo4pd4 -0.00102
21 ua3pd2 -0.00211 -0.00364 38 mo3sc4 -0.00101
22 sc3ua3 -0.00211 -0.01516 27 mo4pd5 -0.00097
23 mo3ua2 -0.00209 -0.03057 14 mo5ad4 -0.00096
24 sc2ua2 -0.00199 -0.01514 28 mo5sc2 -0.00090
25 mo2ua3 -0.00197 -0.01690 26 pd4ad4 -0.00088
26 mo3pd2 -0.00192 -0.00886 34 mo5ua4 -0.00087
27 pd2ad2 -0.00191 -0.01396 31 sc3ua5 -0.00087
28 ua2ad3 -0.00181 -0.02569 19 mo3sc3 -0.00080
29 sc3pd2 -0.00164 -0.01372 32 ua5pd5 -0.00080
30 mo2ad3 -0.00154 -0.00839 36 ua5ad4 -0.00077
31 mo2ua2 -0.00145 -0.02910 16 mo2sc3 -0.00077
32 sc2pd3 -0.00140 -0.02227 22 pd2ad3 -0.00075
33 sc3ad2 -0.00133 -0.01396 30 mo4ad4 -0.00074
34 ua2ad2 -0.00117 -0.03451 11 mo3pd4 -0.00074
35 mo2pd2 -0.00112 -0.03028 15 mo4sc4 -0.00073
36 sc2ad3 -0.00109 -0.03736 9 mo2sc5 -0.00070
37 ua2pd2 -0.00108 -0.00933 33 mo2ua2 -0.00068
38 sc2pd2 -0.00100 -0.02128 23 mo3ad5 -0.00066
39 mo2ad2 -0.00097 -0.03154 12 sc5pd4 -0.00066
40 sc2ad2 -0.00092 -0.00101 39 pd2ad2 -0.00065
ua4ad4 -0.00065
sc5ua2 -0.00064
mo5ad3 -0.00060
sc4pd4 -0.00059
ua5pd4 -0.00059
mo2sc4 -0.00059
sc3ua3 -0.00058
pd3ad4 -0.00058
mo5pd4 -0.00055
sc4ad3 -0.00055
sc4ad4 -0.00054
pd5ad5 -0.00053
mo3ua3 -0.00051
sc4ua2 -0.00050
ua2pd5 -0.00049
ua4pd5 -0.00049
mo4sc2 -0.00049
ua4ad3 -0.00048
mo3sc2 -0.00048
pd2ad5 -0.00048
pd4ad2 -0.00047
sc4ua3 -0.00044
mo3ad3 -0.00044
pd4ad3 -0.00042
mo3ua4 -0.00042
mo5ad5 -0.00042
sc5pd5 -0.00041
sc3pd2 -0.00039
ua5ad3 -0.00039
pd5ad2 -0.00039
sc5ad4 -0.00038
ua3ad4 -0.00037
sc4ad5 -0.00037
mo4ad3 -0.00036
sc2ua3 -0.00035
ua4pd4 -0.00034
sc4pd5 -0.00033
ua4pd3 -0.00031
mo5ua5 -0.00031
mo2ua5 -0.00031
mo5ua3 -0.00031
sc3ua4 -0.00030
sc4pd2 -0.00030
ua5ad5 -0.00030
sc4pd3 -0.00029
sc4ua4 -0.00029
sc2ua5 -0.00028
sc5ad3 -0.00027
mo4sc3 -0.00026
pd2ad4 -0.00026
ua5pd3 -0.00026
sc2ua4 -0.00024
ua4pd2 -0.00024
mo5pd3 -0.00024
sc3ad3 -0.00024
mo5pd5 -0.00022
sc5ad5 -0.00022
sc3pd4 -0.00021
ua2pd3 -0.00021
sc3ad5 -0.00021
sc3pd3 -0.00021
mo4pd2 -0.00021
ua2pd2 -0.00021
mo2ad4 -0.00021
ua3pd5 -0.00021
sc3ua2 -0.00020
mo3pd2 -0.00019
mo2ad3 -0.00019
mo2ad2 -0.00019
mo4ua4 -0.00019
sc5pd3 -0.00019
mo3pd3 -0.00019
mo2pd5 -0.00019
pd3ad2 -0.00018
mo5ua2 -0.00018
sc2pd5 -0.00017
mo2pd4 -0.00017
mo3ad2 -0.00017
mo5pd2 -0.00016
sc3ad4 -0.00016
mo3ua2 -0.00016
mo4ad2 -0.00015
mo4ua3 -0.00015
mo2ua4 -0.00014
mo2ad5 -0.00014
ua3pd2 -0.00014
ua4ad5 -0.00013
mo3ad4 -0.00013
sc2ad4 -0.00012
mo5ad2 -0.00012
ua3ad5 -0.00011
ua2ad5 -0.00011
ua3pd4 -0.00011
ua4ad2 -0.00011
sc5ad2 -9.4E-05
sc2ad5 -8.8E-05
ua3ad3 -8.6E-05
ua3pd3 -8.6E-05
ua2pd4 -8.0E-05
ua2ad4 -7.5E-05
mo4ua2 -7.0E-05
sc3pd5 -6.7E-05
mo2pd2 -6.5E-05
sc2pd4 -5.1E-05
ua3ad2 -4.6E-05
ua2ad2 -4.5E-05
sc4ad2 -4.3E-05
mo2ua3 -3.2E-05
ua5ad2 -3.2E-05
mo3pd5 -2.5E-05
ua5pd2 -1.5E-05
sc2ad3 2.57E-05
sc3ad2 2.58E-05
mo2pd3 4.67E-05
sc2ad2 5.14E-05
ua2ad3 5.60E-05
sc2pd2 6.27E-05
sc2pd3 9.21E-05
mo4pd3 0.000104
sc5pd2 0.000174

Note: UK and Netherlands results are both based on EQ-5D-3 L and are shown in the order of the UK ranking to facilitate comparison. The China results are based on EQ-5D-5 L and are therefore retained in their original within-dataset ranking. More negative coefficients indicate greater reduction in RMSE associated with inclusion of the interaction term. Coefficients shown in bold are not statistically significant at the 5% level

Step 3: Parsimonious modelling using summary interaction terms

Although models including all secondary interaction terms achieved the greatest improvements in model performance, such specifications involve a large number of parameters and are unlikely to be feasible in standard EQ-5D valuation studies. Therefore, in the final step, we explored whether parsimonious interaction structures could capture the key non-additive effects identified in Step 2.

Specifically, we evaluated summary interaction terms that aggregate the effects of multiple secondary interactions. For EQ-5D-3 L, we examined the N3 term, which captures interactions among severe (level 3) problems, and the D1 term, which reflects overall marginal disutility beyond the first problem, as well as their combination (N3D1). For EQ-5D-5 L, we examined analogous specifications including N5, N45, and D1.

The performance of these parsimonious models was compared with that of the ME and fully interacted models using RMSE as the primary criterion, with results summarised in Table 5.

Table 5.

RMSE values of main effects model and models with different interaction terms

Model name RMSE
Netherlands UK China
rmse_main 2.496783 5.54918 1.81246
rmse_all_interaction_terms 1.213041 3.502183 1.507143
rmse_d1 2.079927 3.99069 1.789281
rmse_n3 1.96092 4.740939 /
rmse_n3d1 1.578983 3.640426 /
rmse_ad3 2.399362 5.157859 /
rmse_ad3d1 1.982546 3.731316 /
rmse_n5 / / 1.813585
rmse_n5d1 / / 1.795188
rmse_n45 / / 1.720708
rmse_n45d1 / / 1.698956

Results

There are 30,092, 10,845 and 315,693 observations respectively for the Netherlands, UK and China. Table 1 shows some characteristics of these three saturated datasets. The number of observations per health state vary across three datasets, with the dataset from the Netherlands and China met the recommended sample size of 100 observations per state. The dataset from UK has a lower number of observations for all health states other than 11,111 and 33,333. This is because the UK dataset was collected using a block design, and states 11,111 and 33,333 were included in all blocks.

For modelling, we first estimated a main effects specification and then extended it by including all second-order interaction terms. The extended models yielded lower RMSE values and improved overall fit indices compared to the main effects models. The estimated coefficients for interactions were generally larger when both dimensions were at higher severity levels, and all coefficients were positive across datasets.

Table 2 shows the modelling coefficients and the model performance indicators for both 3 L datasets and Table 3 shows the modelling coefficients and model performance indication for the 5 L dataset. For 3 L datasets, all secondary interaction terms were significant at 0.01 level for the saturated dataset of the Netherlands, except for the terms sc2ad2 and sc2ad3, which were only significant at 0.05 level. In comparison, there were 5 interaction terms in the UK dataset that were not significant at 0.05 level (sc3ua2, sc3ua3, sc2ad2, ua3pd2, ua2pd3) and 2 terms were significant at 0.05 level (sc2ua2, mo3ua3, mo3ad3), with all other terms being significant at 0.01 level. The overall model performance indicators of the Netherlands dataset were better than the UK dataset. A similar pattern was observed for the 5 L dataset of China and only two interaction terms were significant at 0.05 (sc4ad2) and 0.1(sc2ad2) level respectively with all other 158 interaction terms being significant at 0.01 level.

Table 2.

Model performance and coefficients for both 3 L saturated datasets

The Netherlands UK
Main effects Interaction model Main effects Interaction model
Parameter Coef SE Coef SE. Parameter Coef SE Coef SE
mo2 -4.751 0.2 -10.931 0.59 mo2 -10.417 0.443 -19.525 1.082
mo3 -13.728 0.2 -24.008 0.59 mo3 -18.234 0.437 -29.856 1.162
sc2 -3.728 0.2 -9.435 0.59 sc2 -10.417 0.444 -17.308 1.074
sc3 -7.74 0.2 -14.755 0.59 sc3 -14.232 0.437 -22.904 1.161
ua2 -5.037 0.2 -11.258 0.59 ua2 -10.014 0.443 -16.973 1.079
ua3 -11.705 0.2 -21.364 0.59 ua3 -13.163 0.436 -18.935 1.164
pd2 -6.079 0.2 -12.218 0.59 pd2 -12.031 0.443 -17.977 1.084
pd3 -16.136 0.2 -27.03 0.59 pd3 -20.075 0.436 -36.094 1.132
ad2 -5.538 0.2 -11.618 0.59 ad2 -10.188 0.444 -17.929 1.082
ad3 -14.217 0.2 -23.153 0.59 ad3 -17.819 0.435 -34.071 1.161
mo2sc2 2.687 0.482 mo2sc2 5.674 1.035
mo3sc2 3.17 0.482 mo3sc2 5.965 1.052
mo2sc3 3.135 0.482 mo2sc3 6.019 1.042
mo3sc3 4.266 0.482 mo3sc3 6.121 1.044
mo2ua2 1.971 0.482 mo2ua2 5.488 1.029
mo3ua2 2.862 0.482 mo3ua2 6.244 1.048
mo2ua3 2.914 0.482 mo2ua3 4.296 1.048
mo3ua3 5.294 0.482 mo3ua3 2.645 1.042
mo2pd2 1.666 0.482 mo2pd2 5.297 1.037
mo3pd2 2.491 0.482 mo3pd2 3.281 1.042
mo2pd3 2.937 0.482 mo2pd3 6.142 1.043
mo3pd3 5.421 0.482 mo3pd3 6.899 1.048
mo2ad2 1.244 0.482 mo2ad2 4.747 1.044
mo3ad2 2.681 0.482 mo3ad2 4.072 1.048
mo2ad3 1.986 0.482 mo2ad3 2.302 1.047
mo3ad3 4.646 0.482 mo3ad3 5.368 1.048
sc2ua2 2.581 0.482 sc2ua2 2.609 1.033
sc3ua2 2.554 0.482 sc3ua2 1.026 1.05
sc2ua3 3.257 0.482 sc2ua3 3.831 1.055
sc3ua3 2.66 0.482 sc3ua3 0.725 1.04
sc2pd2 1.363 0.482 sc2pd2 4.259 1.038
sc3pd2 1.926 0.482 sc3pd2 3.921 1.046
sc2pd3 1.985 0.482 sc2pd3 5.305 1.051
sc3pd3 3.25 0.481 sc3pd3 4.632 1.042
sc2ad2 0.946 0.482 sc2ad2 0.045 1.033
sc3ad2 1.384 0.482 sc3ad2 3.314 1.052
sc2ad3 1.129 0.482 sc2ad3 5.993 1.054
sc3ad3 1.871 0.482 sc3ad3 6.702 1.04
ua2pd2 1.654 0.482 ua2pd2 1.563 1.037
ua3pd2 2.697 0.482 ua3pd2 0.197 1.048
ua2pd3 2.992 0.482 ua2pd3 4.391 1.052
ua3pd3 4.871 0.482 ua3pd3 2.698 1.044
ua2ad2 1.612 0.482 ua2ad2 6.013 1.04
ua3ad2 2.838 0.482 ua3ad2 3.383 1.05
ua2ad3 2.43 0.482 ua2ad3 6.327 1.046
ua3ad3 4.439 0.482 ua3ad3 5.484 1.039
pd2ad2 2.947 0.482 pd2ad2 4.808 1.038
pd3ad2 4.586 0.482 pd3ad2 9.801 1.047
pd2ad3 3.667 0.482 pd2ad3 7.811 1.05
pd3ad3 6.635 0.482 pd3ad3 13.57 1.04
Constant 69.675 0.27 82.528 0.573 Constant 87 0.37 95.408 0.413
Model performance indicators
RMSE 2.497 1.213 5.549 3.502
R2 0.419 0.437 0.680 0.723
AIC 244,819 243,955 91,696 90,225
BIC 244,910 244,379 91,776 90,596

* Coefficients shown in bold are not statistically significant at the 5% level, whereas coefficients shown in italics are statistically significant at the 5% level

Table 3.

Model performance and coefficients for China 5 L dataset

China
Main effects Interaction model
Parameter Coef SE Coef SE
mo2 -3.84 0.092 -10.698 0.357
mo3 -5.981 0.092 -13.979 0.357
mo4 -9.12 0.092 -17.346 0.357
mo5 -11.257 0.091 -18.689 0.357
sc2 -3.417 0.092 -10.12 0.358
sc3 -5.595 0.092 -12.73 0.358
sc4 -8.069 0.092 -16.237 0.357
sc5 -10.122 0.091 -17.621 0.357
ua2 -3.359 0.092 -8.649 0.357
ua3 -5.568 0.092 -11.85 0.358
ua4 -8.379 0.092 -15.058 0.358
ua5 -10.393 0.091 -17.317 0.357
pd2 -2.897 0.092 -8.614 0.357
pd3 -5.581 0.092 -11.959 0.357
pd4 -9.593 0.092 -17.235 0.358
pd5 -11.125 0.091 -18.738 0.357
ad2 -3.32 0.092 -8.241 0.358
ad3 -6.386 0.092 -13.648 0.358
ad4 -10.74 0.092 -18.18 0.357
ad5 -12.757 0.091 -20.013 0.357
mo2sc2 4.306 0.288
mo2sc3 3.691 0.288
mo2sc4 3.89 0.288
mo2sc5 3.647 0.288
mo2ua2 2.045 0.288
mo2ua3 1.72 0.288
mo2ua4 1.881 0.288
mo2ua5 2.195 0.288
mo2pd2 1.387 0.288
mo2pd3 1.238 0.288
mo2pd4 1.354 0.288
mo2pd5 1.741 0.288
mo2ad2 1.424 0.288
mo2ad3 1.758 0.288
mo2ad4 1.946 0.288
mo2ad5 1.658 0.288
mo3sc2 3.549 0.288
mo3sc3 3.906 0.288
mo3sc4 4.161 0.288
mo3sc5 4.386 0.288
mo3ua2 1.895 0.288
mo3ua3 2.166 0.288
mo3ua4 2.142 0.288
mo3ua5 2.879 0.288
mo3pd2 1.725 0.288
mo3pd3 1.634 0.288
mo3pd4 2.31 0.288
mo3pd5 2.007 0.288
mo3ad2 1.661 0.288
mo3ad3 2.361 0.288
mo3ad4 2.167 0.288
mo3ad5 2.622 0.288
mo4sc2 3.483 0.288
mo4sc3 3.561 0.288
mo4sc4 3.901 0.288
mo4sc5 4.573 0.288
mo4ua2 1.536 0.288
mo4ua3 2.035 0.288
mo4ua4 2.191 0.288
mo4ua5 3.337 0.288
mo4pd2 1.627 0.288
mo4pd3 1.599 0.288
mo4pd4 2.623 0.288
mo4pd5 2.504 0.288
mo4ad2 1.568 0.288
mo4ad3 2.49 0.288
mo4ad4 2.783 0.288
mo4ad5 2.907 0.288
mo5sc2 3.67 0.288
mo5sc3 3.863 0.288
mo5sc4 4.426 0.288
mo5sc5 1.953 0.286
mo5ua2 1.773 0.288
mo5ua3 2.114 0.288
mo5ua4 2.485 0.288
mo5ua5 1.842 0.286
mo5pd2 1.309 0.288
mo5pd3 1.75 0.288
mo5pd4 2.247 0.288
mo5pd5 1.759 0.286
mo5ad2 1.73 0.288
mo5ad3 2.59 0.288
mo5ad4 2.994 0.288
mo5ad5 2.509 0.286
sc2ua2 3.089 0.288
sc2ua3 2.697 0.288
sc2ua4 2.277 0.288
sc2ua5 2.567 0.288
sc2pd2 1.203 0.288
sc2pd3 1.476 0.288
sc2pd4 1.671 0.288
sc2pd5 1.421 0.288
sc2ad2 0.552 0.288
sc2ad3 0.921 0.288
sc2ad4 1.202 0.288
sc2ad5 1.022 0.288
sc3ua2 2.318 0.288
sc3ua3 2.927 0.288
sc3ua4 2.401 0.288
sc3ua5 2.996 0.288
sc3pd2 1.842 0.288
sc3pd3 1.607 0.288
sc3pd4 1.84 0.288
sc3pd5 1.373 0.288
sc3ad2 0.743 0.288
sc3ad3 1.518 0.288
sc3ad4 1.326 0.288
sc3ad5 1.351 0.288
sc4ua2 2.802 0.288
sc4ua3 2.953 0.288
sc4ua4 2.324 0.288
sc4ua5 3.547 0.288
sc4pd2 1.872 0.288
sc4pd3 2.046 0.288
sc4pd4 2.385 0.288
sc4pd5 2.06 0.288
sc4ad2 0.649 0.288
sc4ad3 1.993 0.288
sc4ad4 1.801 0.288
sc4ad5 1.62 0.288
sc5ua2 2.928 0.288
sc5ua3 3.75 0.288
sc5ua4 3.876 0.288
sc5ua5 1.48 0.286
sc5pd2 1.24 0.288
sc5pd3 1.792 0.288
sc5pd4 2.313 0.288
sc5pd5 1.997 0.286
sc5ad2 0.899 0.288
sc5ad3 1.388 0.288
sc5ad4 1.652 0.288
sc5ad5 1.474 0.286
ua2pd2 1.118 0.288
ua2pd3 0.826 0.288
ua2pd4 1.179 0.288
ua2pd5 1.902 0.288
ua2ad2 0.984 0.288
ua2ad3 1.245 0.288
ua2ad4 1.065 0.288
ua2ad5 1.331 0.288
ua3pd2 1.384 0.288
ua3pd3 1.406 0.288
ua3pd4 1.664 0.288
ua3pd5 1.928 0.288
ua3ad2 1.233 0.288
ua3ad3 1.569 0.288
ua3ad4 1.809 0.288
ua3ad5 1.643 0.288
ua4pd2 1.447 0.288
ua4pd3 1.779 0.288
ua4pd4 2.216 0.288
ua4pd5 2.299 0.288
ua4ad2 1.477 0.288
ua4ad3 2.148 0.288
ua4ad4 2.25 0.288
ua4ad5 1.792 0.288
ua5pd2 1.232 0.288
ua5pd3 1.751 0.288
ua5pd4 2.266 0.288
ua5pd5 2.601 0.286
ua5ad2 1.419 0.288
ua5ad3 2.171 0.288
ua5ad4 2.397 0.288
ua5ad5 1.791 0.286
pd2ad2 3.097 0.288
pd2ad3 3.479 0.288
pd2ad4 2.949 0.288
pd2ad5 3.26 0.288
pd3ad2 2.464 0.288
pd3ad3 4.196 0.288
pd3ad4 3.657 0.288
pd3ad5 4.254 0.288
pd4ad2 3.052 0.288
pd4ad3 3.707 0.288
pd4ad4 3.934 0.288
pd4ad5 5.039 0.288
pd5ad2 3.239 0.288
pd5ad3 4.368 0.288
pd5ad4 4.859 0.288
pd5ad5 3.861 0.286
Constant 75.215 0.127 88.443 0.286
Model performance indicators
RMSE 1.812 1.507
R2 0.246 0.255
AIC 2,657,028 2,653,469
BIC 2,657,252 2,655,399

* Coefficients shown in bold are not statistically significant at the 5% level, whereas coefficients shown in italics are statistically significant at the 5% level

From Tables 2 and 3, the parameters with the highest weights are pd3ad3, mo3pd3, mo3ua3 for the Netherlands and pd3ad3, pd3ad2, pd2ad3 for the UK. In comparison, the parameters with the highest weights are pd4ad5, pd5ad4, mo4sc5 for China.

Figures 1, 2 and 3 present the relationship between RMSE and the number of interaction terms included in the model for the UK, Netherlands and China. Across all three datasets, RMSE declines monotonically as interaction terms are added, while the overall magnitude of change remains limited. Corresponding figures for R², AIC, and BIC are presented in the supplementary material and show similar trends.

Table 4 presents the ranking of interaction terms based on their impact on RMSE. In both 3 L datasets, the terms pd3ad3 and mo3pd3 produced the largest reductions in RMSE, with pd3ad3 showing the strongest effect in the Netherlands dataset. In the 5 L dataset from China, the terms pd4ad5 and pd5ad4 had the largest influence, whereas pd5ad5 showed a comparatively smaller effect. The mo3pd3 term, which was important in the 3 L datasets, did not emerge as influential in the 5 L dataset. Across all three datasets, the interaction involving high levels of pain/discomfort and anxiety/depression was consistently among the top-ranked terms.

From Table 4, it is evident that the effect of diminishing marginal utility differs between mild and severe health states, with stronger interactions observed at higher severity levels. To capture these effects efficiently, we selected N3 for the EQ-5D-3 L models and N45 for the EQ-5D-5 L model, representing interactions among severe levels, and incorporated D1 to account for overall marginal disutility effects. This targeted approach ensures that key interaction effects are reflected in the model while maintaining feasibility within realistic sample size constraints.

Table 5 demonstrates that incorporating interaction terms significantly improves model performance across all datasets, as indicated by lower RMSE values compared to the main effects model. Although the absolute reduction is marginal, the relative reduction of RMSE is considerable. Specifically, in the Netherlands dataset, RMSE decreases from 2.50 to 1.21, representing a 51% reduction, while in the UK dataset, RMSE drops from 5.55 to 3.50 (37% reduction). The China dataset shows a more modest 17% reduction (1.81 to 1.51). Notably, while models including all interaction terms achieve the greatest reduction in RMSE, more parsimonious models, such as N3D1 in the Netherlands and UK and N45D1 in China, also yield substantial improvements, suggesting that focusing on key interactions rather than including all possible terms may provide a balance between model parsimony and predictive accuracy.

Discussion

This study investigated the impact of incorporating interaction terms in EQ-5D valuation models using three saturated datasets: EQ-5D-3 L datasets from the Netherlands and the UK, and an EQ-5D-5 L dataset from China. The findings reveal three key insights. First, models that included interaction terms demonstrated improved predictive performance, as reflected in reduced RMSE values and enhanced model fit indicators (AIC, BIC, and R²). Second, all interaction terms were positive, supporting the presence of diminishing marginal utility, where individuals perceive smaller additional losses when multiple health problems are combined. Third, interaction terms involving higher severity levels exhibited the largest coefficients, suggesting that the diminishing marginal utility effect is more sensitive among health states with severe/extreme problems. Importantly, while the results demonstrate the superiority of models with interaction terms, the main effects model also provide sufficient prediction accuracy. This suggests the validity of published studies using main effects model, especially for those studies using efficient design optimized for main effects model [6].

A further finding is that no single universal interaction term emerged across all three datasets, except for interaction terms between high levels between anxiety/depression and pain/discomfort, which captures the effect of experiencing severe or extreme problems in both pain/discomfort and anxiety/depression simultaneously. This interaction was consistently identified as significant in both the 3 L and 5 L datasets, highlighting its potential importance in capturing the compounding effect of severe problems in these two dimensions. However, incorporating secondary interaction terms between these two dimensions alone did not outperform the N3 term in model performance, suggesting that broader interactions involving multiple severe dimensions provide a better representation of valuation patterns [15, 17]. Moreover, in the 5 L dataset, the N5-only term did not outperform the N45 term, indicating that interactions among severe and extreme health problems (N45) better account for valuation responses than focusing solely on extreme levels. These findings suggest that while certain interactions may be consistently significant across datasets, a single specific interaction term like pd3ad3 for EQ-5D-3 L is insufficient to fully capture the complexities of preference-based valuation models.

Based on the findings of this study, we conclude that for EQ-5D-3 L, the inclusion of N3 (capturing interactions among severe levels) and D1 (representing overall marginal disutility effects) appears to be the optimal model specification [15–18]. For EQ-5D-5 L, the combination of N45 and D1 interactions provides the best model fit and predictive accuracy. These interaction terms effectively capture the compounding effects of severe health impairments across multiple dimensions.

Another key contribution of this study is to clarify the role and interpretation of summary interaction terms such as N3, N45, and D1 within EQ-5D valuation models. Conceptually, these terms are often described as capturing non-additive effects arising from the joint presence of multiple problems or severe problems across dimensions. Rather than representing specific pairwise interactions between dimensions [7, 8], summary terms provide a low-dimensional way to account for systematic deviations from strict additivity that arise under particular conditions of severity.

Empirically, evidence from saturated EQ VAS datasets suggests that these terms may be closely related to boundary effects on the valuation scale. In particular, the N3 and N45 terms indicate the presence of at least one dimension at the most severe (or near-most severe) level, a situation in which observed VAS values tend to decline more sharply than predicted by additive main-effects alone. This pattern is consistent with a boundary-induced compression effect, whereby respondents increasingly anchor their valuations toward the lower end of the scale as health states approach the worst imaginable condition.

Under this interpretation, summary interaction terms do not necessarily reflect complex psychological interactions between specific dimensions (e.g., mobility and pain), but instead capture a global adjustment associated with proximity to the lower bound of the valuation scale. Such boundary effects are particularly salient in VAS data, where the finite scale and anchoring at “worst imaginable health” may induce non-linearities as severity accumulates across dimensions. The consistent improvement in model performance associated with N3 and N45 across multiple datasets supports the view that these terms capture a systematic and reproducible feature of the valuation process. Importantly, the mechanisms underlying the valuation of severe health states may differ between VAS and other elicitation methods such as TTO, e.g., EQ VAS has a known “end aversion” effect [11, 19]. While the boundary-related compression observed here is consistent with properties of the VAS scale, TTO tasks involve explicit trade-offs with life duration and may therefore engage different cognitive and decision processes when valuing very poor health states [11]. As such, the interaction patterns identified in this study should be interpreted as reflecting VAS-based valuation behavior and may not directly translate to TTO or DCE data.

This interpretation has important implications for valuation study design. If summary interaction terms primarily reflect boundary effects rather than dimension-specific interactions, their estimation does not require valuation designs that are explicitly optimised to detect between-dimension interactions. Instead, design optimization may benefit from placing greater emphasis on the inclusion of more severe health states, while expanding the total number of health states or observations may not be necessary. Designs that under-represent such states—whether due to efficiency-driven selection or limited health-state coverage—may therefore provide insufficient empirical support for estimating boundary-related effects, even when interaction terms are included in the model [10].

From this perspective, the advantage of summary interaction terms lies precisely in their parsimony [14]. They allow boundary-related non-additivity to be accommodated within conventional modelling frameworks and efficiency-oriented designs, without requiring substantial expansion of the health-state set or a dramatic increase in sample size. This helps explain why these terms have been consistently beneficial in saturated datasets, while their empirical contribution may be difficult to detect in smaller or more restricted designs.

Our findings are consistent with previous research exploring the impact of interaction terms in EQ-5D valuation. Studies such as Jonker et al. [8] and Nicolet et al. [7] also reported that incorporating interactions improved model fit, particularly for severe health states. The present study extends this work by demonstrating that the significance of interaction effects is robust across different datasets and valuation settings. Furthermore, the observed pattern of diminishing marginal utility aligns with prior EQ-5D valuation studies, which have shown that additional losses in utility tend to shrink at higher severity levels. Although the consistent positivity of interaction terms is compatible with diminishing marginal utility, alternative explanations related to VAS scale properties cannot be fully excluded.

However, our results differ from some studies that have found only marginal gains from including interaction terms. This discrepancy may be due to differences in study design, particularly in health state sampling. Whereas earlier studies often relied on small or non-saturated datasets, our analysis utilized full-coverage datasets, allowing for a more comprehensive assessment of interaction effects. These findings suggest that the detectability of interactions is influenced by the breadth of health state sampling, reinforcing the importance of well-designed valuation studies that capture a wide range of health state interactions.

Despite its strengths, this study has several limitations. First, the datasets analyzed were derived from VAS valuation studies. While VAS allows full health state coverage and provides a useful platform for exploring interaction structures, it differs conceptually from TTO and DCE approaches, particularly in how respondents evaluate severe health states. As a result, the extent to which the observed interaction patterns generalize to TTO- or DCE-based valuation remains uncertain. Second, while this study explored interaction effects within existing datasets, it did not directly test alternative experimental designs that might be better optimized for capturing interactions. Future research should examine whether targeted oversampling of high-severity health states or adaptive experimental designs could further improve the estimation of interaction effects. Third, this study focused on two-way (second-order) interactions but did not investigate higher-order interactions (e.g., three-way or four-way interactions). While higher-order interactions may theoretically contribute to valuation models, their complexity increases the risk of overfitting. Future studies should explore whether higher-order interactions are empirically supported and whether their inclusion substantively improves model performance. Last but not least, the datasets used in this study were not designed to be nationally representative, and differences in sampling strategies and respondent characteristics across studies may limit the generalizability of the findings. However, the primary aim of this study is methodological rather than population-based, and the results should be interpreted in this context.

Conclusion

This study shows that interaction effects can improve model fit and predictive accuracy in EQ-5D valuation, particularly for health states with multiple severe problems. However, the gains were modest in absolute terms, suggesting that the main-effects model remains a robust baseline specification for standard valuation studies. Parsimonious summary terms such as N3 and D1 for EQ-5D-3 L and N45 and D1 for EQ-5D-5 L appear to offer a practical way to capture key non-additive effects.

These findings are mainly relevant in a methodological context and may help inform future model specification and valuation study design. However, because this study was based on secondary analysis of saturated EQ VAS datasets, the results should be interpreted cautiously. Further research is needed to examine whether similar interaction structures are observed in TTO-based valuation studies.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (462.8KB, docx)

Acknowledgements

We thank EuroQol Research Foundation for funding this study (Grant number: 92-RA).

Author contributions

Z.Y. conceived and designed the study, coordinated data acquisition, and drafted the initial manuscript. Z.Y. and J.M.R.-G. conducted the statistical analyses and contributed to the interpretation of the results. Z.Y., P.K., and J.B. collected the data. J.M.R.-G. provided methodological expertise on model specification and interaction modelling and critically revised the manuscript for methodological rigor. P.K. contributed to the conceptual framing of the study and interpretation of findings. J.B. contributed to study design and interpretation of results. All authors critically revised the manuscript, approved the final version, and agree to be accountable for all aspects of the work.

Funding

This work was supported by grants 92-RA from the EuroQol Research Foundation.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Ethical approval

Not applicable.

Competing interests

Dr. Yang reports grants from The EuroQol Research Foundation, during the conduct of the study; grants from The EuroQol Research Foundation, outside the submitted work. Dr. Ramos-Goñi reports grants from The EuroQol Research Foundation, during the conduct of the study; grants from The EuroQol Research Foundation, outside the submitted work. Dr. Kind reports grants from The EuroQol Research Foundation, during the conduct of the study; grants from The EuroQol Research Foundation, outside the submitted work. Dr. Busschbach reports grants from The EuroQol Research Foundation, during the conduct of the study; grants from The EuroQol Research Foundation, outside the submitted work. All authors are members of the EuroQol Group.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goni JM, Luo N. EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. PharmacoEconomics. 2016;34(10):993–1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Oppe M, Devlin NJ, van Hout B, Krabbe PF, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17(4):445–53. [DOI] [PubMed] [Google Scholar]
  • 3.Stolk E, Ludwig K, Rand K, van Hout B, Ramos-Goni JM. Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol. Value Health. 2019;22(1):23–30. [DOI] [PubMed] [Google Scholar]
  • 4.Oppe M, Hout B. The ‘power’ of eliciting EQ-5D-5L values: the experimental design of the EQ-VT. EuroQol Working Paper Series [Internet]. 2017; (17003). Available from: https://euroqol.org/wp-content/uploads/2016/10/EuroQol-Working-Paper-Series-Manuscript-17003-Mark-Oppe.pdf
  • 5.Yang Z, Luo N, Bonsel G, Busschbach J, Stolk E. Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter. Value Health. 2018;21(4):456–61. [DOI] [PubMed] [Google Scholar]
  • 6.Yang Z, Luo N, Bonsel G, Busschbach J, Stolk E. Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice. Value Health. 2019;22(1):38–44. [DOI] [PubMed] [Google Scholar]
  • 7.Nicolet A, Groothuis-Oudshoorn CGM, Krabbe PFM. Does Inclusion of Interactions Result in Higher Precision of Estimated Health State Values? Value Health. 2018;21(12):1437–44. [DOI] [PubMed] [Google Scholar]
  • 8.Jonker MF, Donkers B. Interaction Effects in Health State Valuation Studies: An Optimal Scaling Approach. Value Health. 2023;26(4):554–66. [DOI] [PubMed] [Google Scholar]
  • 9.Vasan Thakumar A, Luo N. MSR23 EQ-5D-5L Valuation Studies: Do the Effects of Dimensional Health Problems Interact with Each Other? Value Health. 2023;26(12):S397. [Google Scholar]
  • 10.Yang Z, Feng Z, Busschbach J, Stolk E, Luo N. How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence. Value Health. 2019;22(7):829–36. [DOI] [PubMed] [Google Scholar]
  • 11.Yang Z, Luo N, Oppe M, Bonsel G, Busschbach J, Stolk E. Toward a Smaller Design for EQ-5D-5L Valuation Studies. Value Health. 2019;22(11):1295–302. [DOI] [PubMed] [Google Scholar]
  • 12.Hernandez Alava M, Pudney S, Wailoo A. The EQ-5D-5L Value Set for England: Findings of a Quality Assurance Program. Value Health. 2020;23(5):642–8. [DOI] [PubMed] [Google Scholar]
  • 13.Luo N, Vasan Thakumar A, Cheng LJ, Yang Z, Rand K, Cheung YB, et al. Developing an EQ-5D-5L Value Set for Singapore. PharmacoEconomics. 2025;43(12):1419–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ramos-Goni JM, Pinto-Prades JL, Oppe M, Cabases JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach. Med Care. 2017;55(7):e51–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–108. [DOI] [PubMed] [Google Scholar]
  • 16.Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43(3):203–20. [DOI] [PubMed] [Google Scholar]
  • 17.Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Mak. 2001;21(1):7–16. [DOI] [PubMed] [Google Scholar]
  • 18.Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11(4):341–53. [DOI] [PubMed] [Google Scholar]
  • 19.Devlin NPD, Janssen B. Chapter 3, Analysis of EQ VAS Data. In: (CH). C, editor. Methods for Analysing and Reporting EQ-5D Data: Springer; 2020. [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1 (462.8KB, docx)

Data Availability Statement

No datasets were generated or analysed during the current study.


Articles from Health and Quality of Life Outcomes are provided here courtesy of BMC

RESOURCES